HOME             SERVICES                       PRICING                   FEATURED COMPANIES                NEWS                 CONTACT 

Image description
Image description
Image description
Image description


to learn more about the remarkable story of CVSI, please visit our partner website, click here, and find out how a small, unknown, tiny penny stock company tranformed itself in to a giant! CVSI is now worth a whopping $500 million!

NJOY Holdings

 

Great turn around story of  a E-Ciggrette  Maker

  • From Bankruptcy to

  • $5 Billion Valuation

  • Rasing $300 million

  • Fresh cash to take on

  • The Market Leader JUUL

NJOY Emerges from the Ashes of Bankruptcy with a stunning $5 Billion Valuation.

 

JUUL & NJOY dueling for market share. Who will be standing when the smoke clears?

NJOY the E-Cigarette pioneer was forced to file for bankruptcy protection when one of its biggest product launch failed to catch fire, and the mountain of debt left the company with no other choice.

 

After emerging from the bankruptcy, the company quickly introduced a sleek device and other accessories that are doing well in the market, and it is one of the greatest corporate comeback stories in recent memory.

 

The Wall Street Journal reported that the company is seeking to raise $300 million to fire up its marketing campaign and capture market share from its much bigger, arch rival, JUUL.

 

Image description

The New Marlboro Man! The World’s Largest Cigarette Maker Bets on E-Cigarettes

 

Global cigarette sales are in precipitous decline. Meanwhile, the E-Cigarette and Cannabis sales are exploding. The Marlboro maker Altria Group, which has a market cap of $100 billion, is painfully aware of its declining market share and eroding younger smoker base, as more and more youngsters turning to the discreet and hip E-Cigarette devices.


The Marlboro Man Makes a Bold Move

The world’s largest cigarette maker betting on the new millennial brand that has captured the imagination of young smokers.

Altria CEO Howard Willard spent months discretely negotiating with companies in the burgeoning Cannabis and E-Cig market, and he recently announced a huge deal that surprised the industry and stunned the shareholders. Altria agreed to pay a whopping $13 billion for a 35% stake in a 3 year old startup JUUL.


JUUL, the New Marlboro

The CEO of Altria, owners of the Marlboro brand, had tried and failed miserably to start a new e-cigarette brand, and the growing popularity of JUUL had left him with no other choice, so he did the next best thing, if you can’t beat them, join them! However, some industry experts think that he might have a paid a little too much (JUUL was valued only $300 million in 2017) Altria valued the company at a whopping $38 billion, holy smokes!

 

 

Editor

POTTV Network

 

Sources: The Company, WSJ, Oxbridge Research, POTTV network, Daily Stock Deals


Image description

Cresco Labs, CRLBF, CL


Cresco Labs, based in Chicago is a grower, processor and retailer of premium cannabis with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states (New York, Massachusetts, Maryland). The company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry. Its speed-to-market gives Cresco a competitive advantage as it replicates its model to expand its national footprint. Cresco’s ability to execute is complemented by a brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal.


Editor POTTV network

 

Image description

A Brand New Fashion Accessory for the Modern Marlboro Man, a Nicotine Pouch, Made in Switzerland, and Delivers the Punch in 5 Speed and 7 Flavors.


 

The Marlboro man has added a brand new arsenal to his collection of beautifully designed, must have, nicotine accessories. The latest collection has been developed and designed on the high fashion streets of Switzerland.

 

Philip Morris (Altria) the parent company of Marlboro, the largest cigarette maker in the world, has paid a whopping $372 million for an 80% stake in the Swiss Company.

 

The On! pouch delivers nicotine punch in five speed, and in 7 different flavors, from cinnamon-mint to citrus-berry, and guaranteed to satisfy the NASCAR fanatics, who care about speed and convenience, and the connoisseurs alike.

 

The great variety of flavors and the extra punch has made On! one of the fastest Tobacco Derived Nicotine (TDN) products in America, consumption of (TDN) products grew by a staggering 250%, according to the data from IRI.

 

The high growth potential in a brand new category was compelling for Marlboro to pay a premium for On!, and the company has unparalleled advantage over its rivals for owning a formidable retail distribution network that spans the globe, and it has already started distributing On! to retailers in the United States and overseas.

 

 

 

Editor

POTTV Network

 

Source: The Company, Oxbridge Research, POTTV Network, Daily Stock Deals.



 

Cannabis Therapy Corp, CTCO


Cannabis Therapy Crop., is a development stage company that combines world-class leadership with expert technological know-how in varietal development and extraction of natural, plant-based cannabinoids. The Company is developing proprietary extraction methods and processes, offering highly refined, isolated cannabinoids as both extracts and products targeting the food science, therapeutic and nutraceutical sectors.

Cannabis Therapy Corp’s goal is to achieve a leading role in the manufacturing and marketing of medicinal CBD products by applying the highest biopharma standards and quality controls, and to become a global leader in the research, development, production, testing and marketing of cannabinoids and cannabinoid therapies.

A Multi-Billion Dollar Opportunity


Among the fastest growing markets in the US, legal cannabis has been reported as offering the potential to outpace the expansion of the global smartphone market and medical cannabis is estimated to become an $8.9 billion dollar industry by 2016. To date, twenty-two US states (plus Washington D.C.) have decriminalized marijuana for medical use with more states forecast to join the trend. The market for cannabis products is forecast to hit $10 billion by 2018, growing 64% in 2014 to hit $2.34 billion.


The total global nutraceuticals market reached $142.1 billion in 2011 and is expected to reach $204.8 billion by 2017, growing at a compound annual growth rate of 6.3%, spurred primarily by dietary supplements.Rising health concerns, the growth of key demographics and growing consumer desire to lead a healthy life and avoid dependence on synthetic drugs are identified trends that show no sign of abating. In addition, mergers and acquisitions, new product launches and heart health-enhancing nutraceuticals are predicted to augment market growth.

 


Vaporin, VAPO

 

Vaporin Enters Cannabis Industry Through Distribution Partnership With Terra Tech Corp. (TRTC)


Vaporin Has Developed Proprietary Vaporizing Pen Products for Consummation of Cannabis in Oil, Wax, and Dry Herb Form.

 

Vaporin offers an exciting new smoking alternative for the smokers. Vaporin Electronic Cigarettes resemble traditional cigarettes in look, taste and feel. It’s easy to use, runs on a rechargeable battery and lights up automatically. Users inhale their desired amount of nicotine through the option of numerous delicious flavors. The thing that distinguishes Vaporin vs. traditional cigarettes is, each drag consists of smoke vapors, leaving no ash or butts behind.

Vaporin is always changing the electronic cigarette industry standard, and continues to be the leader the ecig branding, marketing and customer service. Vaporin is constantly growing as America's most trusted brand of electronic cigarette for the following reasons:

  • Quality: Vaporin's e-cigarettes are made with the highest quality

  • Branding and Marketing: Vaporin always comes up with new promotions and unique marketing approaches

  • Customer Service and Support: Vaporin's customer service support team will always go out of their way to make sure our customers are 100% satisfied

  • Warranty: Vaporin offers a 30 day money back guarantee and also a lifetime warranty to loyal customers

 

Image description

Aphria, APHA, Company Profile, Business Summary


Aphria a Success Story, Canadian Pot going mainstream, pushing the boundaries, Legal Pot meets High Finance.  Aphria has successfully transitioned to New York Stock Exchange from OTCQB.


Aphria is a leading global cannabis company, headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities, bringing breakthrough innovation to the global cannabis market. Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.


Key Operating Highlights

  • 92% increase in kilogram equivalents1 sold, reflecting partial period sales from the opening of the Canadian adult-use market, as well as continued sales of medical cannabis to existing and new patients
  • Adjusted gross margins of 47% of net revenue, compared to 64% in prior quarter, as expected, due to lower effective selling prices in adult-use market, as well as temporarily lowered yields and higher production costs related to facilities expansion and implementation of automation
  • Part IV and V expansions of Aphria One awaiting Health Canada approval; application for cultivation licence at Aphria Diamond submitted and also awaiting Health Canada pre-cultivation inspection
  • Announced and closed subsequent to quarter-end of the acquisition of CC Pharma, a leading distributor to pharmacies in Germany
  • Closed acquisition of key operations and licenses in strategic Latin America and Caribbean jurisdictions; subsequently established additional strategic alliances in the region to expand the Company's medical cannabis operations and distribution
  • Listed on the NYSE, providing shareholders greater liquidity
  • Appointed new independent Chair of Board of Directors, Irwin D. Simon, subsequent to quarter-end
  • Ended quarter with strong balance sheet and liquidity, including $152.1 million of cash and $32.7 million of liquid marketable securities, to fund announced Canadian and International growth and facilities expansion

Executive Transition


Aphria Chief Executive Officer Vic Neufeld, and Co-founder Cole Cacciavillani, are both nearing the end of their five-year journey with the Company and will transition out of their executive roles over the coming months but remain on the Board. Working closely with Irwin D. Simon, Aphria's recently appointed independent Chair, and President Jakob Ripshtein, Mr. Neufeld and Mr. Cacciavillani intend to complete a smooth and responsible transition to a globally-minded executive leadership team for the long-term benefit of the Company's patients, shareholders, customers, and employees.

Aphria Chair Irwin D. Simon commented, "Vic and Cole are consummate entrepreneurs. Thanks to their vision, energy and passion, Aphria has become a global player in an industry that didn't even exist five years ago. On behalf of the entire Aphria team, I want to express my gratitude to both. I look forward to working with them to further build Aphria's leadership team and continue driving long-term value for our patients, customers and employees into the future."


"When the Canadian medical cannabis market opened up five years ago, Cole was growing millions of potted flowers in Leamington, and he understood that cannabis was a natural product extension for the founding team's decades of experience as greenhouse growers in Leamington," said Mr. Neufeld. "Now with legalization and globalization, including a huge market opportunity with positive developments in the U.S., Aphria's next generation of leadership may take the reins. Building and leading a Company like Aphria, which exploded from an idea in late 2013 to our many successes to-date, has been an incredible journey, despite the toll it has taken on health, family and personal priorities."  "Vic and I have worked tirelessly for decades, building great businesses, but now in our sixties, it is time for both of us to step back from the demands of leading a world-class organization. Endless meetings, travel, deadlines, talent search - the list of executive responsibilities will only continue to grow," said Mr. Cacciavillani.


"Succession is the plan. Cole and I have informed the Board, and they have agreed, that we will begin the transition process immediately, and at the appropriate time, we will both step down from executive positions at Aphria. We continue to have the greatest pride in what Aphria has achieved, and its future has never looked brighter. From continued technology advancements, to continued support of scientific developments, to amazing adult-use brands, to globalization strategies, and most of all, the hundreds of dedicated passionate team members that have joined Aphria, we are well positioned to be a dominant player," concluded Mr. Neufeld.


The Board has requested that, following the transition, Mr. Neufeld and Mr. Cacciavillani continue to apply their knowledge and expertise as special advisors to both the Chair and the President, ensuring a smooth transition of institutional experience and strategic advice until a new CEO is appointed.


Source: The Company, OxBridge Research, Daily Stock Deals, OTC Stock Wire   POTtvNetwork

 

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. 

If you want to get your company featured on Daily Stock Deal or want to learn more, please contact the Editor. Thanks you!